FDA inspection
Corwood Labs Inc: FDA inspection ending Jun 12, 2008
FDA inspection 521482 · Voluntary Action Indicated (VAI) · Hauppauge, NY
Key facts
| Inspection ID | 521482 |
|---|---|
| Firm | Corwood Labs Inc |
| FEI number | 2419515 |
| Address | 55 Adams Ave |
| City | Hauppauge |
| State | NY |
| ZIP | 11788-3605 |
| Fiscal year | 2008 |
| Inspection end date | Jun 12, 2008 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs|Generic Drug Evaluation|Unapproved and Misbranded Drugs |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data